- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Lincoln Pharma to begin API production at Khatraj facility in 1- 2 years

Ahmedabad: Lincoln Pharmaceuticals Limited is expected to commence the commercial production of Active Pharmaceutical Ingredients (APIs) at its newly built manufacturing facility in Khatraj, Gandhinagar, Gujarat.
The facility, located at Trimul Estate, recently completed successfull trial run and is now awaiting additional product approval from the Food and Drugs Control Administration (FDCA).
Commercial operations are expected to begin within one to two years, the company said in a regulatory filing to the BSE.
"We are pleased to inform you that the new manufacturing facility of the Company located at Block No-176, Trimul Estate, Khatraj, Dis-Gandhinagar, Gujarat has successfully completed its trial run. Further, the facility is expected to commence the commercial production of APIs (Active Pharmaceutical Ingredients) within 1 to 2 years depending upon additional product permission received from Food & Drugs Control Administration," Lincoln stated.
Read also: Lincoln Pharma reports 22.8 percent rise in standalone net profit at Rs. 21.6 crore in Q3 FY23
Set up in the year 1979, the manufacturing facility of Lincoln is based at Khatraj, Gujarat sharing the same dais as with the international standards. Its lab has been given ISO 9001:2015 certifications. The company also furthermore plan to expand the capabilities in the US and UK markets.
The manufacturing facility at Khatraj produces only Non betalactum tablets, capsules, ointments/creams, dry-powder suspensions, sterile ophthalmic ointments, SVP injectables, oral liquids, dry-powder injections, eye/ear drops, etc.
Read also: Amalgamation scheme of Lincoln Parenteral, Lincoln Pharma approved by NCLT
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751